Bdh Industries [BDH] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bdh Industries wins in 9 metrics, Sun Pharmaceutical wins in 11 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBdh IndustriesSun PharmaceuticalBetter
P/E Ratio (TTM)27.4836.74Bdh Industries
Price-to-Book Ratio4.215.30Bdh Industries
Debt-to-Equity Ratio1.433.26Bdh Industries
PEG Ratio1.66-1.89Sun Pharmaceutical
EV/EBITDA21.9123.33Bdh Industries
Profit Margin (TTM)13.84%19.29%Sun Pharmaceutical
Operating Margin (TTM)10.21%24.34%Sun Pharmaceutical
EBITDA Margin (TTM)10.21%24.34%Sun Pharmaceutical
Return on Equity13.49%15.08%Sun Pharmaceutical
Return on Assets (TTM)10.67%11.87%Sun Pharmaceutical
Free Cash Flow (TTM)$145.56M$119.44BSun Pharmaceutical
Dividend Yield2.98%1.26%Bdh Industries
1-Year Return54.33%-14.34%Bdh Industries
Price-to-Sales Ratio (TTM)4.217.11Bdh Industries
Enterprise Value$2.60B$3,578.34BSun Pharmaceutical
EV/Revenue Ratio3.776.65Bdh Industries
Gross Profit Margin (TTM)26.19%79.58%Sun Pharmaceutical
Revenue per Share (TTM)$120$224Sun Pharmaceutical
Earnings per Share (Diluted)$18.32$43.39Sun Pharmaceutical
Beta (Stock Volatility)0.200.31Bdh Industries
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Bdh Industries vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bdh Industries0.69%11.61%60.02%89.98%93.22%44.47%
Sun Pharmaceutical-0.31%0.56%4.66%-1.86%-3.66%-13.43%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bdh Industries54.33%242.53%556.26%579.28%2,107.68%1,672.36%
Sun Pharmaceutical-14.34%71.30%219.01%80.56%692.58%2,617.04%

News Based Sentiment: Bdh Industries vs Sun Pharmaceutical

Bdh Industries

News based Sentiment: MIXED

BDH Industries experienced a significant stock price increase and positive developments in promoter holding, but these gains are offset by analyst concerns about overvaluation. This creates a mixed investment narrative, making October a noteworthy but not definitively positive month for the company.

View Bdh Industries News Sentiment Analysis

Sun Pharmaceutical

News based Sentiment: MIXED

October was a mixed month for Sun Pharma, with a significant acquisition balanced against a decline in net profit. Positive analyst ratings and tariff news provide offsetting positive signals, making it a month of notable, but not overwhelmingly positive, developments for investors.

View Sun Pharmaceutical News Sentiment Analysis

Performance & Financial Health Analysis: Bdh Industries vs Sun Pharmaceutical

MetricBDHSUNPHARMA
Market Information
Market Cap i₹3.02B₹3.92T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i16,7032,839,112
90 Day Avg. Volume i17,0962,655,594
Last Close₹506.80₹1,631.20
52 Week Range₹241.00 - ₹519.80₹1,548.00 - ₹1,952.25
% from 52W High-2.50%-16.45%
All-Time High₹519.80 (Oct 03, 2025)₹1,960.35 (Sep 30, 2024)
% from All-Time High-2.50%-16.79%
Growth Metrics
Quarterly Revenue Growth0.15%0.10%
Quarterly Earnings Growth0.17%-0.20%
Financial Health
Profit Margin (TTM) i0.14%0.19%
Operating Margin (TTM) i0.10%0.24%
Return on Equity (TTM) i0.13%0.15%
Debt to Equity (MRQ) i1.433.26
Cash & Liquidity
Book Value per Share (MRQ)₹119.43₹300.99
Cash per Share (MRQ)₹54.12₹108.88
Operating Cash Flow (TTM) i₹227.86M₹110.84B
Levered Free Cash Flow (TTM) i₹92.73M₹109.29B
Dividends
Last 12-Month Dividend Yield i2.98%1.26%
Last 12-Month Dividend i₹9.00₹21.00

Valuation & Enterprise Metrics Analysis: Bdh Industries vs Sun Pharmaceutical

MetricBDHSUNPHARMA
Price Ratios
P/E Ratio (TTM) i27.4836.74
Forward P/E i69.9148.79
PEG Ratio i1.66-1.89
Price to Sales (TTM) i4.217.11
Price to Book (MRQ) i4.215.30
Market Capitalization
Market Capitalization i₹3.02B₹3.92T
Enterprise Value i₹2.60B₹3.58T
Enterprise Value Metrics
Enterprise to Revenue i3.776.65
Enterprise to EBITDA i21.9123.33
Risk & Other Metrics
Beta i0.200.31
Book Value per Share (MRQ) i₹119.43₹300.99

Financial Statements Comparison: Bdh Industries vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BDHSUNPHARMA
Revenue/Sales i₹186.24M₹137.86B
Cost of Goods Sold i₹137.46M₹28.15B
Gross Profit i₹48.79M₹109.71B
Research & Development iN/AN/A
Operating Income (EBIT) i₹19.01M₹33.72B
EBITDA i₹26.63M₹47.66B
Pre-Tax Income i₹24.41M₹31.73B
Income Tax i₹6.14M₹8.70B
Net Income (Profit) i₹18.27M₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BDHSUNPHARMA
Cash & Equivalents i₹307.12M₹102.69B
Total Current Assets i₹667.49M₹526.24B
Total Current Liabilities i₹169.17M₹181.94B
Long-Term Debt iN/A₹3.58B
Total Shareholders Equity i₹687.62M₹724.86B
Retained Earnings i₹457.59M₹578.62B
Property, Plant & Equipment i₹146.88M₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BDHSUNPHARMA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBDHSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i16,7032,839,112
Average Daily Volume (90 Day) i17,0962,655,594
Shares Outstanding i5.76M2.40B
Float Shares i2.21M1.04B
% Held by Insiders i0.57%0.56%
% Held by Institutions i0.00%0.25%

Dividend Analysis & Yield Comparison: Bdh Industries vs Sun Pharmaceutical

MetricBDHSUNPHARMA
Last 12-Month Dividend i₹9.00₹21.00
Last 12-Month Dividend Yield i2.98%1.26%
3-Year Avg Annual Dividend i₹5.53₹14.67
3-Year Avg Dividend Yield i1.92%0.46%
3-Year Total Dividends i₹16.60₹44.00
Ex-Dividend DateAug 01, 2025Jul 07, 2025